Engineered B cells should be induced to differentiate into plasma cells and become long-lived, protein-secreting cells to perform potential oncology therapeutic functions. When B cells bind antigens in vivo, this complex B cell differentiation process involves proliferation, isotype switching, affinity maturation, and terminal differentiation. As a profound metamorphosis of the genome to...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek